Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SQZ Biotechnologies Q2 EPS $(0.68)

SQZ Biotechnologies (NYSE:SQZ) reported quarterly losses of $(0.68) per share.

byMichael Horton

August 4, 2021

1 minute read

SQZ Biotechnologies (NYSE:SQZ) reported quarterly losses of $(0.68) per share.

Earnings

Earnings Preview: NeuroOne Medical Tech

By Benzinga Insights

Today, 11:55 PM

NeuroOne Medical Tech (NASDAQ:NMTC) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement.

NMTC

Supply Chain Issues Hit Neogen’s Q4 Margins, Earnings

By Vandana Singh

Today, 11:55 PM

Neogen Corporation (NASDAQ:NEOG) reported a Q4 net income of $0.15 per share, missing a consensus estimate of $0.16 Q4 Revenues…

NEOG

Keybanc Maintains Underweight on Greif, Lowers Price Target to $58

By Benzinga Newsdesk

Today, 11:55 PM

Keybanc analyst Adam Josephson maintains Greif (NYSE:GEF) with a Underweight and lowers the price target from $63 to $58.

GEF

Maxar Technologies Chief Financial Officer Biggs Porter To Retire In 2023

By Bill Haddad

Today, 11:55 PM

Maxar Technologies (NYSE:MAXR) (TSX:MAXR), a provider of comprehensive space solutions and secure, precise, geospatial intelligence, today announced that Executive Vice President and Chief Financial Officer (CFO) Biggs

MAXR

SQZ Biotechnologies Q2 EPS $(0.68)

Related Posts

Earnings Preview: NeuroOne Medical Tech

Supply Chain Issues Hit Neogen’s Q4 Margins, Earnings

Keybanc Maintains Underweight on Greif, Lowers Price Target to $58

Maxar Technologies Chief Financial Officer Biggs Porter To Retire In 2023